These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3983219)

  • 1. Tolerance, cross-tolerance, and receptors after chronic nicotine or oxotremorine.
    Marks MJ; Collins AC
    Pharmacol Biochem Behav; 1985 Feb; 22(2):283-91. PubMed ID: 3983219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Species differences in diisopropylfluorophosphate-induced decreases in the number of brain nicotinic receptors.
    Van de Kamp JL; Collins AC
    Pharmacol Biochem Behav; 1992 May; 42(1):131-41. PubMed ID: 1528936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic influences on tolerance development with chronic oxotremorine infusion.
    Marks MJ; Romm E; Collins AC
    Pharmacol Biochem Behav; 1987 Aug; 27(4):723-32. PubMed ID: 3659096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-tolerance between muscarinic agonists: role of muscarinic receptors.
    Collins AC; Smolen TN; Smolen A; Medhurst LJ
    Pharmacol Biochem Behav; 1987 Jan; 26(1):173-82. PubMed ID: 3562489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in sensitivity to nicotine and brain nicotinic receptors following chronic nicotine and corticosterone treatments in mice.
    Robinson SF; Grun EU; Pauly JR; Collins AC
    Pharmacol Biochem Behav; 1996 Jul; 54(3):587-93. PubMed ID: 8743633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissociation of decreased numbers of muscarinic receptors from tolerance to DFP.
    Smolen TN; Smolen A; Collins AC
    Pharmacol Biochem Behav; 1986 Dec; 25(6):1293-301. PubMed ID: 3809233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nicotine-induced tolerance and receptor changes in four mouse strains.
    Marks MJ; Romm E; Gaffney DK; Collins AC
    J Pharmacol Exp Ther; 1986 Jun; 237(3):809-19. PubMed ID: 3712280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time course study of the effects of chronic nicotine infusion on drug response and brain receptors.
    Marks MJ; Stitzel JA; Collins AC
    J Pharmacol Exp Ther; 1985 Dec; 235(3):619-28. PubMed ID: 4078726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential alterations of cholinergic muscarinic receptors during chronic and acute tolerance to organophosphorus insecticides.
    Costa LG; Schwab BW; Murphy SD
    Biochem Pharmacol; 1982 Nov; 31(21):3407-13. PubMed ID: 7150362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-response analysis of nicotine tolerance and receptor changes in two inbred mouse strains.
    Marks MJ; Stitzel JA; Collins AC
    J Pharmacol Exp Ther; 1986 Nov; 239(2):358-64. PubMed ID: 3772799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic ethanol or nicotine treatment results in partial cross-tolerance between these agents.
    Burch JB; de Fiebre CM; Marks MJ; Collins AC
    Psychopharmacology (Berl); 1988; 95(4):452-8. PubMed ID: 3145516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of kinetics of nicotine administration on tolerance development and receptor levels.
    Marks MJ; Stitzel JA; Collins AC
    Pharmacol Biochem Behav; 1987 Jul; 27(3):505-12. PubMed ID: 2821553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of a single dose of an acetylcholinesterase inhibitor on oxotremorine- and nicotine-induced hypothermia in mice.
    Clement JG
    Pharmacol Biochem Behav; 1991 Aug; 39(4):929-34. PubMed ID: 1763113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of brain nicotinic receptors by chronic agonist infusion.
    Bhat RV; Turner SL; Selvaag SR; Marks MJ; Collins AC
    J Neurochem; 1991 Jun; 56(6):1932-9. PubMed ID: 2027007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation by nicotine on binding of cerebral muscarinic receptors with muscarinic agonist and antagonist.
    Wang H; Cui WY; Liu CH
    Zhongguo Yao Li Xue Bao; 1996 Nov; 17(6):497-9. PubMed ID: 9863140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective changes in sensitivity to cholinergic agonists and receptor changes elicited by continuous physostigmine infusion.
    Bhat RV; Turner SL; Marks MJ; Collins AC
    J Pharmacol Exp Ther; 1990 Oct; 255(1):187-96. PubMed ID: 2213555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic influences on acute responses to nicotine and nicotine tolerance in the mouse.
    Collins AC; Miner LL; Marks MJ
    Pharmacol Biochem Behav; 1988 May; 30(1):269-78. PubMed ID: 3174752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of chronic oxotremorine treatment on spatial learning and tolerance development in mice.
    Wehner JM; Upchurch M
    Pharmacol Biochem Behav; 1989 Feb; 32(2):543-51. PubMed ID: 2727016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Affinity ligands and related agents for brain muscarinic and nicotinic cholinergic receptors.
    Abood LG; Saraswati M; Lerner-Marmarosh N; Hashmi M
    Biochem Pharmacol; 1993 May; 45(10):2143-8. PubMed ID: 8512596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tolerance to and cross tolerance between ethanol and nicotine.
    Collins AC; Burch JB; de Fiebre CM; Marks MJ
    Pharmacol Biochem Behav; 1988 Feb; 29(2):365-73. PubMed ID: 3362930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.